CHINA TRADITIONAL CHINESE MEDICINE HOLDINGS CO. LIMITED

China Traditional Chinese Medicine Holdings Co. Limited

570 HK0000056256

Pharmaceuticals

Market Closed - Hong Kong S.E. Other stock markets 04:08:03 2025-07-11 am EDT			5-day change	1st Jan Change
2.270 ^HKD	+2.25%		+3.18%	-1.73%

Jun. 25	China Traditional Chinese Medicine's New Application for Unit's Depression Drug Accepted in China	MT
Jun. 25	China Traditional Chinese Medicine Holdings Co. Limited Announces NMPA Acceptance of New Drug Application of Yushuda Tablets	CI

China Traditional Chinese Medicine's Stock Bolts on Privatization Offer

Published on 02/22/2024 at 06:49, updated on 02/22/2024 at 06:50

This article is reserved for members

Unlock the article: REGISTER NOW!

100% Free Registration

Already a customer? Log In

Latest news about China Traditional Chinese Medicine Holdings Co. Limited

China Traditional Chinese Medicine's New Application for Unit's Depression Drug Accepted in China	Jun. 25	MT
China Traditional Chinese Medicine Holdings Co. Limited Announces NMPA Acceptance of New Drug Application of Yushuda Tablets	Jun. 25	CI
China Traditional Chinese Medicine Holdings Co. Limited Announces Adjustments to the Composition of Board Committees, Effective from 20 June 2025	Jun. 20	CI
China Traditional Chinese Medicine Says Lan Qingshan Ceased To Serve As A Vice President	May. 14	RE
China Traditional Chinese Medicine Holdings Co. Limited Announces Joint Company Secretary Changes	May. 14	CI
China Traditional Chinese Medicine Controlling Shareholder Boosts Stake	Apr. 09	MT
China Traditional Chinese Medicine Says Controlling Shareholder Acquired 50.4 Million Shares Of Co	Apr. 08	RE
China Traditional Chinese Medicine Holdings Co. Limited Reports Earnings Results for the Full Year Ended December 31, 2024	Mar. 25	CI
Henlius Biotech shareholders reject take-private offer from China's Fosun	Jan. 22	RE
China Traditional Chinese Medicine Warns of Steep Profit Decline	Jan. 15	MT
Hina Traditional Chinese Medicine Holdings Co. Limited Provides Unaudited Consolidated for the Earnings Guidance for the Year Ended 31 December 2024	Jan. 15	CI
China Traditional Chinese Medicine Holdings Co. Limited Announces Change of Non-Executive Directors	Jan. 15	CI
Sinopharm Common Wealth Company Limited cancelled the acquisition of 67.54% stake in China Traditional Chinese Medicine Holdings Co. Limited from China Asset Management Co. Ltd., China Asset Management (Hong Kong) Limited and others.	24-10-17	CI
China Traditional Chinese Medicine Holdings Co. Limited Announces Executive, Board and Committee Appointments	24-09-27	CI
China TCM Holdings' H1 Profit Falls 64% as Revenue Slips 10%	24-08-29	MT
China Traditional Chinese Medicine Holdings Co. Limited Reports Earnings Results for the Half Year Ended June 30, 2024	24-08-28	CI
China Traditional Chinese Medicine Holdings Co. Limited Provides Consolidated Earnings Guidance for the Six Months Ended 30 June 2024	24-08-21	CI
China Traditional Chinese Medicine, Sinopharm Update on Privatization Process Status	24-05-14	MT
China Traditional Chinese Medicine Posts 94% Profit Growth in 2023	24-03-22	MT
China Traditional Chinese Medicine Holdings Co. Limited Reports Earnings Results for the Full Year Ended December 31, 2023	24-03-21	CI
China Traditional Chinese Medicine Holdings Co. Limited Announces Re-Designation of CHENG Xueren from Managing Director to Non-Executive Director	24-03-21	CI
China Traditional Chinese Medicine Holdings Co. Limited Announces Board Changes	24-03-21	CI
China Traditional Chinese Medicine's Stock Bolts on Privatization Offer	24-02-22	MT
China stocks extend gains led by coal, AI; HK shares up	24-02-22	RE
Hong Kong Stocks Hover Near Two-Month Highs Amid Mixed Corporate Earnings	24-02-22	MT

Chart China Traditional Chinese Medicine Holdings Co. Limited

Duration

Period

Chart China Traditional Chinese Medicine Holdings Co. Limited

570: Dynamic Chart

China Traditional Chinese Medicine Holdings Co. Limited is principally engaged in the manufacture and sales of traditional Chinese medicine (TCM). The Company operates through 12 subsidiaries, including Sinopharm Group Dezhong (Foshan) Pharmaceutical Co., Ltd., Sinopharm Group Feng Liao Xing (Foshan) Pharmaceutical Co., Ltd., Sinopharm Group Guangdong Medi-World Pharmaceutical Co., Ltd., Sinopharm Group Luya (Shandong) Pharmaceutical Co., Ltd., Sinopharm Group Feng Liao Xing (Foshan) Medicinal Material & Slices Co., Ltd., Foshan Winteam Pharmaceutical Sales Company Limited, Sinopharm Group Tongjitang (Guizhou) Pharmaceutical Co., Ltd., Sinopharm Group Jingfang (Anhui) Pharmaceutical Co., Ltd., Sinopharm Group Longlife (Guizhou) Pharmaceutical Co., Ltd., Qinghai Pulante Pharmaceutical Co., Ltd., Guizhou Zhongtai Biological Technology Company Limited and its subsidiaries and Jiangyin Tianjiang Pharmaceutical Co., Ltd. and its subsidiaries.

Employees

16,753

Sector

Pharmaceuticals

Calendar

Jul. 18 - Extraordinary Sahreholders Meeting

More about the company